Living with Parkinson's disease often means managing more than just physical tremors. It can also involve significant challenges with mood and cognitive clarity. Recent research looked at how a class of medications called GLP-1 receptor agonists—which include Exenatide, Lixisenatide, Liraglutide, and NLY01—might help manage these symptoms.
By looking at data from 850 patients, the analysis found that these medications were linked to significant improvements in motor function. These are the physical movements affected by Parkinson's. The study also noted improvements in mood and cognitive function during follow-up periods. While the mood findings came from an exploratory part of the study, they still showed a positive trend.
It is important to note that these results come from a broad look at different studies, which means some variation exists in how well the treatments worked for movement. Because the data comes from various sources, more specific research is needed to confirm exactly how much these medications can help each individual patient.
